Relationship Between Adalimumab Concentrations, Antidrug Antibodies, and Disease Activity in Rheumatoid Arthritis: A Cross-Sectional Observational Study.

Lisa K Stamp Paula E Keating Christopher M A Frampton Murray L Barclay Niamh C Fanning Melanie J Millier Paul A Hessian John L O'Donnell

Published in: The Journal of rheumatology (2024)

ADA concentration correlates negatively with markers of inflammatory disease activity in RA, including IL-6. ADA concentration in the range 5 to 7 mg/L over the dose interval are associated with better disease control.

Keyphrases

disease activity
rheumatoid arthritis
juvenile idiopathic arthritis
rheumatoid arthritis patients
ankylosing spondylitis
systemic lupus erythematosus
interstitial lung disease
oxidative stress
hidradenitis suppurativa